| 标题 |
TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma Myeloma and Leukemia 作者:Swaminathan Iyer; Christina Poh; Jasmine Zain; Christiane Querfeld; John Reneau; et al 出版日期:2026-08-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)